Catalyst Wire Dossier Catalyst Wire Dossier

Xience V stent (everolimus-eluting)

· Abbott Vascular
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xience V stent (everolimus-eluting), covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period [Phase 3]

See pricing